Industry Research Reports
Home > Reports > Service & Software > Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Service & Software
Published Date: 2026-08-15
Pages: 164 Pages
Report ld: 5579274
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Microphysiological System Market Size(US$)
CAGR 2026-2032
16.2%
Market Size,2032
USD 719
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 292 million
Market Forecast in 2032(Value)
US$ 719 million
CAGR
16.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Microphysiological System market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Microphysiological Systems (MPS) are advanced in vitro models that use human-derived cells, tissues, or organoids together with technologies such as three-dimensional culture, microfluidics, extracellular matrices, dynamic perfusion, mechanical stimulation, and integrated sensing to reproduce key structural, functional, and physiological characteristics of human tissues or organs. MPS include Organ-on-Chip systems, multi-organ platforms, organoid-based MPS, and certain engineered 3D tissue models. These systems can simulate cell-cell interactions, tissue barriers, fluid shear stress, and inter-organ communication. They are mainly used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing, with the goal of improving the human relevance and predictive value of preclinical research.Microphysiological Systems (MPS) vary significantly in price depending on platform format, cell source, tissue model complexity, throughput, and the level of integration with perfusion, imaging, and automation. In 2025–2026, basic MPS chips or 3D culture consumables are generally priced at around US$50–1,000 per chip or plate, while complex human cell-based or organoid model kits typically range from US$500–5,000 per kit. Platforms equipped with pumping, perfusion, or culture-control functions generally cost about US$5,000–30,000 per system, while high-throughput automated MPS workstations may reach US$50,000–150,000 or more per system.
The upstream value chain mainly includes human primary cells, induced pluripotent stem cells, organoids, culture media, extracellular matrices, hydrogels, PDMS, COC/COP, glass, porous membranes, sensors, and microfluidic components. Midstream companies develop and integrate MPS chips, 3D tissue models, perfusion-control devices, and automated platforms. Downstream users mainly include pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, and regulatory agencies. MPS platforms are primarily used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing.
Market Drivers
Growing Regulatory Support for Non-Animal Testing Methods
Regulatory agencies are increasingly encouraging the use of New Approach Methodologies, including microphysiological systems, organ-on-chip platforms, organoids, and computational models. In April 2025, the FDA released a roadmap to reduce reliance on animal testing in preclinical safety studies and specifically highlighted human-based models such as organ-on-chip systems. This regulatory shift is strengthening demand for validated MPS platforms in pharmaceutical safety and efficacy assessment.
Increasing Demand for Human-Relevant Preclinical Models
Traditional 2D cell cultures often fail to reproduce complex tissue architecture and physiological functions, while animal models may show species-specific differences in metabolism, immune response, and drug toxicity. MPS platforms recreate important biochemical, mechanical, and physiological conditions using human-derived cells and tissues, improving their potential to predict human drug responses and supporting broader adoption in drug discovery and development.
Rising Pharmaceutical R&D Efficiency Requirements
Pharmaceutical and biotechnology companies are seeking technologies that can identify ineffective or toxic candidates earlier in development. MPS platforms can support drug screening, ADME/DMPK studies, toxicity testing, disease modeling, and efficacy assessment using physiologically relevant human models. NIH continues to support tissue-chip programs designed to improve predictions of drug safety and toxicity in humans, strengthening the technology’s position within preclinical research workflows.
Market Restraints
High Platform and Experimental Costs
MPS experiments may require specialized chips or culture plates, human primary or stem-cell-derived cells, extracellular matrices, sensors, perfusion equipment, imaging systems, and dedicated analytical workflows. These requirements make MPS studies more expensive and operationally demanding than conventional 2D cell culture, particularly for small biotechnology companies and academic laboratories with limited budgets.
Insufficient Standardization and Reproducibility
Commercial MPS platforms differ substantially in materials, channel architecture, cell sources, extracellular matrices, flow conditions, assay endpoints, and operating protocols. This heterogeneity can create challenges in comparing results between laboratories and platforms. Wider regulatory and pharmaceutical adoption therefore requires improved quality control, reproducibility, standardized reporting, and fit-for-purpose validation criteria. OECD guidance increasingly emphasizes quality-management and fit-for-purpose considerations for MPS-related regulatory data.
Dependence on High-Quality Human Cells and Biological Materials
MPS performance is highly dependent on primary human cells, induced pluripotent stem-cell-derived cells, organoids, culture media, and extracellular matrices. Variability between donors and production batches, limited availability of certain mature cell types, and difficulties maintaining stable phenotypes during long-term culture can reduce reproducibility and complicate large-scale deployment. Market Opportunities
Expansion into Regulatory Toxicology and Safety Assessment
One of the largest opportunities for MPS is its transition from an academic research tool to a qualified platform for regulatory and industrial safety assessment. Liver, cardiac, kidney, lung, immune, and barrier models have particular potential for evaluating organ-specific toxicity. FDA and NIH collaboration on New Approach Methodologies is creating a more favorable environment for validated human-based models to enter formal drug-development workflows.
Development of High-Throughput and Automated MPS Platforms
Integration with multi-well formats, automated liquid handling, high-content imaging, biosensors, and data-analysis software can substantially increase MPS throughput and reproducibility. The industry is moving beyond manually operated individual chips toward scalable platforms capable of running dozens or hundreds of tissue models simultaneously, making MPS more compatible with pharmaceutical screening workflows and increasing recurring demand for consumables.
Integration with Organoids, iPSC Technology and AI
Combining MPS with patient-derived organoids, induced pluripotent stem cells, gene editing, and artificial intelligence can enable more disease-specific and patient-specific models. Such platforms could support precision medicine, patient stratification, rare-disease research, and prediction of individual drug responses. Multi-organ MPS further creates opportunities for studying systemic pharmacology, PK/PD relationships, metabolism, and organ-to-organ interactions.
Market Challenges
Balancing Physiological Complexity with Throughput and Scalability
Increasing biological realism often requires multiple cell types, vascular interfaces, extracellular matrices, mechanical stimulation, dynamic perfusion, and real-time sensing. However, greater complexity usually increases operating difficulty, cost, variability, and assay duration. Achieving sufficient physiological relevance while maintaining reproducibility, throughput, automation, and commercial scalability remains a fundamental technical challenge.
Extensive Validation Required for Regulatory Acceptance
Regulatory interest in MPS is increasing, but formal use in decision-making requires robust evidence demonstrating reproducibility, reliability, defined applicability domains, and correlation with human clinical outcomes. Cross-laboratory studies, reference-compound testing, standardized protocols, and comparison against existing methods remain necessary before individual MPS models can achieve broad regulatory acceptance.
Fragmentation of Technologies and Commercial Platforms
The MPS market includes organ-on-chip systems, organoid-based models, engineered 3D tissues, membrane and membrane-free platforms, passive and pump-driven systems, and single- and multi-organ configurations. No single architecture has emerged as the universal industry standard. This fragmentation increases platform-selection risks for pharmaceutical companies and creates significant R&D and commercialization challenges for MPS suppliers.
MARKET SEGMENTATION
By Company
- Emulate
- MIMETAS
- TissUse
- CN Bio Innovations
- AIM Biotech
- AlveoliX
- Beonchip
- React4life
- InSphero
- NETRI
- SynVivo
- BiomimX
- Dynamic42
- Kirkstall
- Cherry Biotech
- Micronit
- Cellbox Labs
- REVIVO BioSystems
- MesoBioTech
- Beijing Daxiang Biotech
- AVATARGET
- Suzhou Jiyan Biopharmaceutical
- Altis Biosystems
- 28bio
- Bi/ond
- Ananda Devices
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Liver MPS
- Lung MPS
- Cardiac MPS
- Kidney MPS
- Gastrointestinal MPS
- Neural/Brain MPS
- Other
Segment by Application
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
Segment by Category
- Single-organ MPS
- Multi-organ MPS
Segment by Division
- Organ-on-Chip Systems
- Organoid-based MPS
- 3D Engineered Tissue MPS
- Others
REPORT SCOPE
The global Microphysiological System market is strategically segmented by company, region (country), by Type, and by End User. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by End User for 2021-2032.
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Microphysiological System market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Microphysiological System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Liver MPS
1.2.3 Lung MPS
1.2.4 Cardiac MPS
1.2.5 Kidney MPS
1.2.6 Gastrointestinal MPS
1.2.7 Neural/Brain MPS
1.2.8 Other
1.3 Market by End User
1.3.1 Global Market Share by End User: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microphysiological System Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Microphysiological System Market Share by Revenue, by Region (2021-2026)
2.4 Global Microphysiological System Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Microphysiological System Market Size and Prospective (2021-2032)
2.5.2 Europe Microphysiological System Market Size and Prospective (2021-2032)
2.5.3 China Microphysiological System Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Microphysiological System Historical Market Size by Type (2021-2026)
3.2 Global Microphysiological System Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Microphysiological System
4 Breakdown Data by End User
4.1 Global Microphysiological System Historical Market Size by End User (2021-2026)
4.2 Global Microphysiological System Forecasted Market Size by End User (2027-2032)
4.3 New Sources of Growth in Microphysiological System Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Microphysiological System Players by Revenue (2021-2026)
5.1.2 Global Microphysiological System Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Microphysiological System Revenue
5.4 Global Microphysiological System Market Concentration Analysis
5.4.1 Global Microphysiological System Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Microphysiological System Revenue in 2025
5.5 Global Key Players of Microphysiological System Head Offices and Areas Served
5.6 Global Key Players of Microphysiological System, Product and Application
5.7 Global Key Players of Microphysiological System, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Microphysiological System Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Microphysiological System Market Size by Type (2021-2026)
6.1.2.2 North America Microphysiological System Market Share by Type (2021-2026)
6.1.3 North America Market Size by End User
6.1.3.1 North America Microphysiological System Market Size by End User (2021-2026)
6.1.3.2 North America Microphysiological System Market Share by End User (2021-2026)
6.1.4 North America Microphysiological System Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Microphysiological System Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Microphysiological System Market Size by Type (2021-2026)
6.2.2.2 Europe Microphysiological System Market Share by Type (2021-2026)
6.2.3 Europe Market Size by End User
6.2.3.1 Europe Microphysiological System Market Size by End User (2021-2026)
6.2.3.2 Europe Microphysiological System Market Share by End User (2021-2026)
6.2.4 Europe Microphysiological System Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Microphysiological System Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Microphysiological System Market Size by Type (2021-2026)
6.3.2.2 China Microphysiological System Market Share by Type (2021-2026)
6.3.3 China Market Size by End User
6.3.3.1 China Microphysiological System Market Size by End User (2021-2026)
6.3.3.2 China Microphysiological System Market Share by End User (2021-2026)
6.3.4 China Microphysiological System Major Customers
6.3.5 China Market Trends and Opportunities
7 Key Player Profiles
7.1 Emulate
7.1.1 Emulate Company Details
7.1.2 Emulate Business Overview
7.1.3 Emulate Microphysiological System Introduction
7.1.4 Emulate Revenue in Microphysiological System Business (2021-2026)
7.1.5 Emulate Recent Development
7.2 MIMETAS
7.2.1 MIMETAS Company Details
7.2.2 MIMETAS Business Overview
7.2.3 MIMETAS Microphysiological System Introduction
7.2.4 MIMETAS Revenue in Microphysiological System Business (2021-2026)
7.2.5 MIMETAS Recent Development
7.3 TissUse
7.3.1 TissUse Company Details
7.3.2 TissUse Business Overview
7.3.3 TissUse Microphysiological System Introduction
7.3.4 TissUse Revenue in Microphysiological System Business (2021-2026)
7.3.5 TissUse Recent Development
7.4 CN Bio Innovations
7.4.1 CN Bio Innovations Company Details
7.4.2 CN Bio Innovations Business Overview
7.4.3 CN Bio Innovations Microphysiological System Introduction
7.4.4 CN Bio Innovations Revenue in Microphysiological System Business (2021-2026)
7.4.5 CN Bio Innovations Recent Development
7.5 AIM Biotech
7.5.1 AIM Biotech Company Details
7.5.2 AIM Biotech Business Overview
7.5.3 AIM Biotech Microphysiological System Introduction
7.5.4 AIM Biotech Revenue in Microphysiological System Business (2021-2026)
7.5.5 AIM Biotech Recent Development
7.6 AlveoliX
7.6.1 AlveoliX Company Details
7.6.2 AlveoliX Business Overview
7.6.3 AlveoliX Microphysiological System Introduction
7.6.4 AlveoliX Revenue in Microphysiological System Business (2021-2026)
7.6.5 AlveoliX Recent Development
7.7 Beonchip
7.7.1 Beonchip Company Details
7.7.2 Beonchip Business Overview
7.7.3 Beonchip Microphysiological System Introduction
7.7.4 Beonchip Revenue in Microphysiological System Business (2021-2026)
7.7.5 Beonchip Recent Development
7.8 React4life
7.8.1 React4life Company Details
7.8.2 React4life Business Overview
7.8.3 React4life Microphysiological System Introduction
7.8.4 React4life Revenue in Microphysiological System Business (2021-2026)
7.8.5 React4life Recent Development
7.9 InSphero
7.9.1 InSphero Company Details
7.9.2 InSphero Business Overview
7.9.3 InSphero Microphysiological System Introduction
7.9.4 InSphero Revenue in Microphysiological System Business (2021-2026)
7.9.5 InSphero Recent Development
7.10 NETRI
7.10.1 NETRI Company Details
7.10.2 NETRI Business Overview
7.10.3 NETRI Microphysiological System Introduction
7.10.4 NETRI Revenue in Microphysiological System Business (2021-2026)
7.10.5 NETRI Recent Development
7.11 SynVivo
7.11.1 SynVivo Company Details
7.11.2 SynVivo Business Overview
7.11.3 SynVivo Microphysiological System Introduction
7.11.4 SynVivo Revenue in Microphysiological System Business (2021-2026)
7.11.5 SynVivo Recent Development
7.12 BiomimX
7.12.1 BiomimX Company Details
7.12.2 BiomimX Business Overview
7.12.3 BiomimX Microphysiological System Introduction
7.12.4 BiomimX Revenue in Microphysiological System Business (2021-2026)
7.12.5 BiomimX Recent Development
7.13 Dynamic42
7.13.1 Dynamic42 Company Details
7.13.2 Dynamic42 Business Overview
7.13.3 Dynamic42 Microphysiological System Introduction
7.13.4 Dynamic42 Revenue in Microphysiological System Business (2021-2026)
7.13.5 Dynamic42 Recent Development
7.14 Kirkstall
7.14.1 Kirkstall Company Details
7.14.2 Kirkstall Business Overview
7.14.3 Kirkstall Microphysiological System Introduction
7.14.4 Kirkstall Revenue in Microphysiological System Business (2021-2026)
7.14.5 Kirkstall Recent Development
7.15 Cherry Biotech
7.15.1 Cherry Biotech Company Details
7.15.2 Cherry Biotech Business Overview
7.15.3 Cherry Biotech Microphysiological System Introduction
7.15.4 Cherry Biotech Revenue in Microphysiological System Business (2021-2026)
7.15.5 Cherry Biotech Recent Development
7.16 Micronit
7.16.1 Micronit Company Details
7.16.2 Micronit Business Overview
7.16.3 Micronit Microphysiological System Introduction
7.16.4 Micronit Revenue in Microphysiological System Business (2021-2026)
7.16.5 Micronit Recent Development
7.17 Cellbox Labs
7.17.1 Cellbox Labs Company Details
7.17.2 Cellbox Labs Business Overview
7.17.3 Cellbox Labs Microphysiological System Introduction
7.17.4 Cellbox Labs Revenue in Microphysiological System Business (2021-2026)
7.17.5 Cellbox Labs Recent Development
7.18 REVIVO BioSystems
7.18.1 REVIVO BioSystems Company Details
7.18.2 REVIVO BioSystems Business Overview
7.18.3 REVIVO BioSystems Microphysiological System Introduction
7.18.4 REVIVO BioSystems Revenue in Microphysiological System Business (2021-2026)
7.18.5 REVIVO BioSystems Recent Development
7.19 MesoBioTech
7.19.1 MesoBioTech Company Details
7.19.2 MesoBioTech Business Overview
7.19.3 MesoBioTech Microphysiological System Introduction
7.19.4 MesoBioTech Revenue in Microphysiological System Business (2021-2026)
7.19.5 MesoBioTech Recent Development
7.20 Beijing Daxiang Biotech
7.20.1 Beijing Daxiang Biotech Company Details
7.20.2 Beijing Daxiang Biotech Business Overview
7.20.3 Beijing Daxiang Biotech Microphysiological System Introduction
7.20.4 Beijing Daxiang Biotech Revenue in Microphysiological System Business (2021-2026)
7.20.5 Beijing Daxiang Biotech Recent Development
7.21 AVATARGET
7.21.1 AVATARGET Company Details
7.21.2 AVATARGET Business Overview
7.21.3 AVATARGET Microphysiological System Introduction
7.21.4 AVATARGET Revenue in Microphysiological System Business (2021-2026)
7.21.5 AVATARGET Recent Development
7.22 Suzhou Jiyan Biopharmaceutical
7.22.1 Suzhou Jiyan Biopharmaceutical Company Details
7.22.2 Suzhou Jiyan Biopharmaceutical Business Overview
7.22.3 Suzhou Jiyan Biopharmaceutical Microphysiological System Introduction
7.22.4 Suzhou Jiyan Biopharmaceutical Revenue in Microphysiological System Business (2021-2026)
7.22.5 Suzhou Jiyan Biopharmaceutical Recent Development
7.23 Altis Biosystems
7.23.1 Altis Biosystems Company Details
7.23.2 Altis Biosystems Business Overview
7.23.3 Altis Biosystems Microphysiological System Introduction
7.23.4 Altis Biosystems Revenue in Microphysiological System Business (2021-2026)
7.23.5 Altis Biosystems Recent Development
7.24 28bio
7.24.1 28bio Company Details
7.24.2 28bio Business Overview
7.24.3 28bio Microphysiological System Introduction
7.24.4 28bio Revenue in Microphysiological System Business (2021-2026)
7.24.5 28bio Recent Development
7.25 Bi/ond
7.25.1 Bi/ond Company Details
7.25.2 Bi/ond Business Overview
7.25.3 Bi/ond Microphysiological System Introduction
7.25.4 Bi/ond Revenue in Microphysiological System Business (2021-2026)
7.25.5 Bi/ond Recent Development
7.26 Ananda Devices
7.26.1 Ananda Devices Company Details
7.26.2 Ananda Devices Business Overview
7.26.3 Ananda Devices Microphysiological System Introduction
7.26.4 Ananda Devices Revenue in Microphysiological System Business (2021-2026)
7.26.5 Ananda Devices Recent Development
8 Microphysiological System Market Dynamics
8.1 Microphysiological System Industry Trends
8.2 Microphysiological System Market Drivers
8.3 Microphysiological System Market Challenges
8.4 Microphysiological System Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Microphysiological System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Microphysiological System Market Size Growth by End User (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Microphysiological System Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Microphysiological System Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Microphysiological System Revenue Share by Region (2021-2026)
Table 6. Global Microphysiological System Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Microphysiological System Revenue Share Forecast by Region (2027-2032)
Table 8. Global Microphysiological System Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Microphysiological System Market Share by Revenue, by Type (2021-2026)
Table 10. Global Microphysiological System Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Microphysiological System Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Microphysiological System Market Size by End User (2021-2026) & (US$ Million)
Table 14. Global Microphysiological System Market Share by Revenue, by End User (2021-2026)
Table 15. Global Microphysiological System Forecasted Market Size by End User (2027-2032) & (US$ Million)
Table 16. Global Microphysiological System Market Share by Revenue, by End User (2027-2032)
Table 17. New Sources of Growth in Microphysiological System Applications
Table 18. Global Microphysiological System Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Microphysiological System Market Share by Players (2021-2026)
Table 20. Global Top Microphysiological System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2025)
Table 21. Ranking of Global Top Microphysiological System Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Microphysiological System Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Microphysiological System, Headquarters and Area Served
Table 24. Global Key Players of Microphysiological System, Product and Application
Table 25. Global Key Players of Microphysiological System, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Microphysiological System Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Microphysiological System Market Share by Revenue, by Company (2021-2026)
Table 29. North America Microphysiological System Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Microphysiological System Market Size by End User (2021-2026) & (US$ Million)
Table 31. Europe Microphysiological System Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Microphysiological System Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Microphysiological System Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Microphysiological System Market Size by End User (2021-2026) & (US$ Million)
Table 35. China Microphysiological System Revenue by Company (2021-2026) & (US$ Million)
Table 36. China Microphysiological System Market Share by Revenue, by Company (2021-2026)
Table 37. China Microphysiological System Market Size by Type (2021-2026) & (US$ Million)
Table 38. China Microphysiological System Market Size by End User (2021-2026) & (US$ Million)
Table 39. Emulate Company Details
Table 40. Emulate Business Overview
Table 41. Emulate Microphysiological System Product
Table 42. Emulate Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 43. Emulate Recent Development
Table 44. MIMETAS Company Details
Table 45. MIMETAS Business Overview
Table 46. MIMETAS Microphysiological System Product
Table 47. MIMETAS Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 48. MIMETAS Recent Development
Table 49. TissUse Company Details
Table 50. TissUse Business Overview
Table 51. TissUse Microphysiological System Product
Table 52. TissUse Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 53. TissUse Recent Development
Table 54. CN Bio Innovations Company Details
Table 55. CN Bio Innovations Business Overview
Table 56. CN Bio Innovations Microphysiological System Product
Table 57. CN Bio Innovations Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 58. CN Bio Innovations Recent Development
Table 59. AIM Biotech Company Details
Table 60. AIM Biotech Business Overview
Table 61. AIM Biotech Microphysiological System Product
Table 62. AIM Biotech Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 63. AIM Biotech Recent Development
Table 64. AlveoliX Company Details
Table 65. AlveoliX Business Overview
Table 66. AlveoliX Microphysiological System Product
Table 67. AlveoliX Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 68. AlveoliX Recent Development
Table 69. Beonchip Company Details
Table 70. Beonchip Business Overview
Table 71. Beonchip Microphysiological System Product
Table 72. Beonchip Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 73. Beonchip Recent Development
Table 74. React4life Company Details
Table 75. React4life Business Overview
Table 76. React4life Microphysiological System Product
Table 77. React4life Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 78. React4life Recent Development
Table 79. InSphero Company Details
Table 80. InSphero Business Overview
Table 81. InSphero Microphysiological System Product
Table 82. InSphero Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 83. InSphero Recent Development
Table 84. NETRI Company Details
Table 85. NETRI Business Overview
Table 86. NETRI Microphysiological System Product
Table 87. NETRI Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 88. NETRI Recent Development
Table 89. SynVivo Company Details
Table 90. SynVivo Business Overview
Table 91. SynVivo Microphysiological System Product
Table 92. SynVivo Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 93. SynVivo Recent Development
Table 94. BiomimX Company Details
Table 95. BiomimX Business Overview
Table 96. BiomimX Microphysiological System Product
Table 97. BiomimX Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 98. BiomimX Recent Development
Table 99. Dynamic42 Company Details
Table 100. Dynamic42 Business Overview
Table 101. Dynamic42 Microphysiological System Product
Table 102. Dynamic42 Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 103. Dynamic42 Recent Development
Table 104. Kirkstall Company Details
Table 105. Kirkstall Business Overview
Table 106. Kirkstall Microphysiological System Product
Table 107. Kirkstall Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 108. Kirkstall Recent Development
Table 109. Cherry Biotech Company Details
Table 110. Cherry Biotech Business Overview
Table 111. Cherry Biotech Microphysiological System Product
Table 112. Cherry Biotech Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 113. Cherry Biotech Recent Development
Table 114. Micronit Company Details
Table 115. Micronit Business Overview
Table 116. Micronit Microphysiological System Product
Table 117. Micronit Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 118. Micronit Recent Development
Table 119. Cellbox Labs Company Details
Table 120. Cellbox Labs Business Overview
Table 121. Cellbox Labs Microphysiological System Product
Table 122. Cellbox Labs Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 123. Cellbox Labs Recent Development
Table 124. REVIVO BioSystems Company Details
Table 125. REVIVO BioSystems Business Overview
Table 126. REVIVO BioSystems Microphysiological System Product
Table 127. REVIVO BioSystems Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 128. REVIVO BioSystems Recent Development
Table 129. MesoBioTech Company Details
Table 130. MesoBioTech Business Overview
Table 131. MesoBioTech Microphysiological System Product
Table 132. MesoBioTech Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 133. MesoBioTech Recent Development
Table 134. Beijing Daxiang Biotech Company Details
Table 135. Beijing Daxiang Biotech Business Overview
Table 136. Beijing Daxiang Biotech Microphysiological System Product
Table 137. Beijing Daxiang Biotech Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 138. Beijing Daxiang Biotech Recent Development
Table 139. AVATARGET Company Details
Table 140. AVATARGET Business Overview
Table 141. AVATARGET Microphysiological System Product
Table 142. AVATARGET Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 143. AVATARGET Recent Development
Table 144. Suzhou Jiyan Biopharmaceutical Company Details
Table 145. Suzhou Jiyan Biopharmaceutical Business Overview
Table 146. Suzhou Jiyan Biopharmaceutical Microphysiological System Product
Table 147. Suzhou Jiyan Biopharmaceutical Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 148. Suzhou Jiyan Biopharmaceutical Recent Development
Table 149. Altis Biosystems Company Details
Table 150. Altis Biosystems Business Overview
Table 151. Altis Biosystems Microphysiological System Product
Table 152. Altis Biosystems Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 153. Altis Biosystems Recent Development
Table 154. 28bio Company Details
Table 155. 28bio Business Overview
Table 156. 28bio Microphysiological System Product
Table 157. 28bio Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 158. 28bio Recent Development
Table 159. Bi/ond Company Details
Table 160. Bi/ond Business Overview
Table 161. Bi/ond Microphysiological System Product
Table 162. Bi/ond Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 163. Bi/ond Recent Development
Table 164. Ananda Devices Company Details
Table 165. Ananda Devices Business Overview
Table 166. Ananda Devices Microphysiological System Product
Table 167. Ananda Devices Revenue in Microphysiological System Business (2021-2026) & (US$ Million)
Table 168. Ananda Devices Recent Development
Table 169. Microphysiological System Market Trends
Table 170. Microphysiological System Market Drivers
Table 171. Microphysiological System Market Challenges
Table 172. Microphysiological System Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Microphysiological System Product Picture
Figure 2. Global Microphysiological System Market Share by Type: 2025 vs 2032
Figure 3. Liver MPS Features
Figure 4. Lung MPS Features
Figure 5. Cardiac MPS Features
Figure 6. Kidney MPS Features
Figure 7. Gastrointestinal MPS Features
Figure 8. Neural/Brain MPS Features
Figure 9. Other Features
Figure 10. Global Microphysiological System Market Share by End User: 2025 vs 2032
Figure 11. Pharmaceutical & Biotechnology Companies
Figure 12. Academic & Research Institutes
Figure 13. Others
Figure 14. Microphysiological System Report Years Considered
Figure 15. Global Microphysiological System Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 16. Global Microphysiological System Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Microphysiological System Market Share by Revenue, by Region: 2021 vs 2025
Figure 18. North America Microphysiological System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Europe Microphysiological System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. China Microphysiological System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Global Microphysiological System Market Share by Players in 2025
Figure 22. Global Top Microphysiological System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2025)
Figure 23. The Top 10 and 5 Players Market Share by Microphysiological System Revenue in 2025
Figure 24. North America Microphysiological System Market Share by Type (2021-2026)
Figure 25. North America Microphysiological System Market Share by End User (2021-2026)
Figure 26. Europe Microphysiological System Market Share by Type (2021-2026)
Figure 27. Europe Microphysiological System Market Share by End User (2021-2026)
Figure 28. China Microphysiological System Market Share by Type (2021-2026)
Figure 29. China Microphysiological System Market Share by End User (2021-2026)
Figure 30. Emulate Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 31. MIMETAS Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 32. TissUse Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 33. CN Bio Innovations Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 34. AIM Biotech Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 35. AlveoliX Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 36. Beonchip Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 37. React4life Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 38. InSphero Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 39. NETRI Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 40. SynVivo Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 41. BiomimX Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 42. Dynamic42 Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 43. Kirkstall Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 44. Cherry Biotech Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 45. Micronit Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 46. Cellbox Labs Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 47. REVIVO BioSystems Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 48. MesoBioTech Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 49. Beijing Daxiang Biotech Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 50. AVATARGET Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 51. Suzhou Jiyan Biopharmaceutical Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 52. Altis Biosystems Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 53. 28bio Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 54. Bi/ond Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 55. Ananda Devices Revenue Growth Rate in Microphysiological System Business (2021-2026)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Microphysiological System in 2032?
The global market size of Microphysiological System in 2032 was 719 Million USD.
Which companies rank high in the global Microphysiological System market?
What is the annual compound growth rate of the global Microphysiological System market size from 2026 to 2032?
What was the global market size of Microphysiological System in 2026?
Which region is expected to have the highest market share?
Related Reports
Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Microphysiological System market is projected to grow from US$ 250 million in 2025 to US$ 719 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 183
USD 4900.00
(Single User License)
Global Microphysiological System Market Research Report 2026
The global Microphysiological System market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 163
USD 2900.00
(Single User License)
Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Microphysiological System was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 175
USD 3950.00
(Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Published Date: 2025-10-14
Pages: 222
USD 3950.00
(Single User License)
Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 180
USD 3950.00
(Single User License)
Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 121
USD 4250.00
(Single User License)
Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-13
Pages: 177
USD 4900.00
(Single User License)
Global Microphysiological System Market Research Report 2025
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published Date: 2025-10-13
Pages: 119
USD 2900.00
(Single User License)
Global and China Microphysiological System Market Report & Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 165
USD 4350.00
(Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 168
USD 3950.00
(Single User License)
Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Microphysiological System market is projected to grow from US$ 250 million in 2025 to US$ 719 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 183
USD 4900.00 (Single User License)Global Microphysiological System Market Research Report 2026
The global Microphysiological System market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 163
USD 2900.00 (Single User License)Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Microphysiological System was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 175
USD 3950.00 (Single User License)Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Published: 2025-10-14
Pages: 222
USD 3950.00 (Single User License)Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 180
USD 3950.00 (Single User License)Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 121
USD 4250.00 (Single User License)Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-13
Pages: 177
USD 4900.00 (Single User License)Global Microphysiological System Market Research Report 2025
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published: 2025-10-13
Pages: 119
USD 2900.00 (Single User License)Global and China Microphysiological System Market Report & Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 165
USD 4350.00 (Single User License)Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 168
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now